ALZAMEND NEURO INC. -

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

25 مارس 2025 07:00:01 بحسب Nasdaq GlobeNewswire

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

18 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

11 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

04 مارس 2025 07:10:00 بحسب Nasdaq GlobeNewswire

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

25 فبراير 2025 07:00:59 بحسب Nasdaq GlobeNewswire